Brokerages Set ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) PT at $18.86
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received a consensus recommendation of “Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. Nine research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have covered the stock in the last year […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received a consensus recommendation of “Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. Nine research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have covered the stock in the last year […]
